SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (5030)12/6/1997 4:45:00 PM
From: JFitnich  Read Replies (2) | Respond to of 17367
 
Hey Guys: I've been a subscriber to the THESTREET.com for about
2 months now. I have to agree with Andrew, the journalist's name
is Jesee Eisinger. I think the spelling's right. He writes
great articles about biotech and the big pharmas. The article
he did on Biotime (gatorade for the blood)was excellent.

Anyway, I subscribed because of Cramer's articles and I havn't been
dissapointed. The excellent anaylysis on BIotech is a bonus.
It is by far one of the best sites out there for relevant info.
I'll quit my advertising now but in my opinion it's worth the bucks.

JF



To: aknahow who wrote (5030)12/7/1997 10:36:00 AM
From: chirodoc  Read Replies (1) | Respond to of 17367
 
<<<<<<off topic

<<<<< But if one wants a beat down group golds are great.

.....read that demand and prodcution are about equal--4-5 tons per year.

......central banks and investors hold about 50 tons.

......central banks are planning to sell on upticks in price or even sell just to raise capital--at least that is what i heard. long term bearish until either inlfation picks up, we have a disaster, or central banks change their mind.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News